Onabotulinum toxin-A can safely improve sleep bruxism

Onabotulinum toxin-A can safely improve sleep bruxism

(HealthDay)—Onabotulinum toxin-A (BoNT-A) injections can improve sleep bruxism, according to a study published online Jan. 17 in Neurology.

William G. Ondo, M.D., from the Methodist Neurological Institute in Houston, and colleagues recruited 31 patients aged 18 to 85 years with clinically diagnosed sleep bruxism confirmed by polysomnography. Twenty-three patients were randomized to either BoNT-A injection (13 patients) or placebo (10 ; nine completed the study). Participants were assessed at four to eight weeks after the initial treatment visit.

The researchers found that clinical global impression (P < 0.05) and visual analog scale of change (P < 0.05) in bruxism and in pain favored the BoNT-A group. There was no significant change in any exploratory end points; total sleep time and number/duration of bruxing episodes favored the BoNT-A group. A cosmetic change in smile was reported by two participants randomized to BoNT-A. There were no reports of dysphagia or masticatory adverse events.

"BoNT-A effectively and safely improved sleep in this placebo-controlled pilot trial," the authors write. "A large multicenter trial is needed to confirm these encouraging data."

Two authors disclosed financial ties to Allergan; Allergan Pharmaceuticals funded the study.

Explore further

Botulinum toxin does not cure common forms of neck pain

More information: Abstract
Full Text
Journal information: Neurology

Copyright © 2018 HealthDay. All rights reserved.

Citation: Onabotulinum toxin-A can safely improve sleep bruxism (2018, January 18) retrieved 22 October 2019 from https://medicalxpress.com/news/2018-01-onabotulinum-toxin-a-safely-bruxism.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more